Skip to main content
SpringerLink
Log in

Biological Subtypes of Breast Cancer

  • Chapter
  • First Online:
Breast Cancer Biology for the Radiation Oncologist

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1323 Accesses

Abstract

Breast cancer is no longer thought of as a single disease, but rather as collection of subtypes characterized by molecular signatures. The use of gene array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bertucci F, Finetti P et al (2005) Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 65:2170–2178

    Article  CAS  PubMed  Google Scholar 

  • Carey LA, Dees EC et al (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329–2334

    Article  CAS  PubMed  Google Scholar 

  • Cheang MC, Chia SK et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736–750

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Colleoni M, Rotmensz N et al (2004) Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol 15:1633–1639

    Article  CAS  PubMed  Google Scholar 

  • Colleoni M, Viale G et al (2008) Expression of ER, PGR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol 19:465–472

    Article  CAS  PubMed  Google Scholar 

  • Dent R et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434

    Article  PubMed  Google Scholar 

  • Dent R, Hanna WM et al (2009) Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat 115:423–428

    Article  PubMed  Google Scholar 

  • Fernandez-Morales LA, Segui MA et al (2007) Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status. Clin Breast Cancer 7:559–564

    Article  CAS  PubMed  Google Scholar 

  • Fisher B, Bryant J et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685

    CAS  PubMed  Google Scholar 

  • Gabos Z, Sinha R et al (2006) Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24(36):5658–5663

    Article  CAS  PubMed  Google Scholar 

  • Goldstein NS, Decker D et al (2007) Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 110:1687–1696

    Article  CAS  PubMed  Google Scholar 

  • Guarneri V, Broglio K et al (2006) Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. J Clin Oncol 24:1037–1044

    Article  PubMed  Google Scholar 

  • Haffty BG, Yang Q et al (2006) Locoregional relapse and distant metstasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24:5652–5657

    Article  PubMed  Google Scholar 

  • Kennecke H, Yerushalmi R et al (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28(20):3271–3277

    Article  PubMed  Google Scholar 

  • Kuerer HM, Newman LA et al (1999) Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460–469

    CAS  PubMed  Google Scholar 

  • Liedtke C, Mazouni C et al (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26:1275–1281

    Article  PubMed  Google Scholar 

  • Mamounas E, Tang G et al (2010) Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node0negative, estrogen-receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 28:1677–1683

    Article  PubMed Central  PubMed  Google Scholar 

  • Nguyen PL, Taghian AG et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER2 is associated with local and distant recurrence after breast-conserving therapies. J Clin Oncol 26:2373–2378

    Article  PubMed  Google Scholar 

  • Park S et al (2012) Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast 21:50–57

    Article  PubMed  Google Scholar 

  • Perou CM, Sorlie T et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752

    Article  CAS  PubMed  Google Scholar 

  • Rody A, Karn T et al (2007) The erb2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial. Breast 16:235–240

    Article  CAS  PubMed  Google Scholar 

  • Rouzier R, Perou CM et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678–5685

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Munoz A, Garcia-Tapiador AM et al (2008) Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Clin Trans Oncol 10:646–653

    Article  CAS  Google Scholar 

  • Sihto H, Lundin J et al (2011) Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res 13:R87

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sorlie T, Perou CM et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sorlie T, Tibshirani R et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sotiriou C et al (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100:10393–10398

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • van’t Veer LJ, Dai H et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–6

    Google Scholar 

  • Viani G, Afonso S et al (2007) Adjuvant trastuzumab in the treatment of her-2 positive early breast cancer: a meta-analysis of published randomized trials. BMC Cancer 7:153

    Article  PubMed Central  PubMed  Google Scholar 

  • Voduc K, Cheang M et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1584–1691

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwestern University, 676 N. St. Clair, Suite 850, Chicago, IL, 60611, USA

    Sara E. Barnato & William J. Gradishar

Authors
  1. Sara E. Barnato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William J. Gradishar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William J. Gradishar .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA

    Jonathan Strauss

  2. Division of Radiation Oncology, Stritch School of Medicine, Cardinal Bernardin Cancer Center, Chicago, Illinois, USA

    William Small

  3. Dept. Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

    Gayle E. Woloschak

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Barnato, S.E., Gradishar, W.J. (2015). Biological Subtypes of Breast Cancer. In: Strauss, J., Small, W., Woloschak, G. (eds) Breast Cancer Biology for the Radiation Oncologist. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2014_1043

Download citation

  • DOI: https://doi.org/10.1007/174_2014_1043

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-31219-9

  • Online ISBN: 978-3-642-31220-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation